May corporate presentation

  1. 25,991 Posts.
    lightbulb Created with Sketch. 1465
    https://www.immutep.com/files/content/investor/analyst-report/2025/Immutep%20Corporate%20Presentation_May%202025.pdf

    Correct me If I'm wrong but I can't see if or where this has made it onto these boards....

    Good sort of a read but the reason for my posting is that immutep have referenced a couple of
    points that interested me...

    1..at one point they referenced of "retaining control of EFTI and having freedom to operate it..

    2..a couple of pages later they published a graph of high profile drugs that have had their
    patents lapse or will by 2028...In immuteps opinion EFTI has the potential to add 12 years
    to these drugs exclusivity period...

    please read for yourself because I'm not sure I've said this the correct way...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.5¢
Change
0.015(5.77%)
Mkt cap ! $414.6M
Open High Low Value Volume
25.5¢ 28.3¢ 25.5¢ $693.8K 2.535M

Buyers (Bids)

No. Vol. Price($)
13 215022 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 104088 15
View Market Depth
Last trade - 12.57pm 07/08/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.